HBV Citations List: August 2022

Literature Citations

1. Assessment of Myrcludex or Heparin Antiviral Activity on HBV Infection Using a 3-Dimensional Primary Human Hepatocyte Culture System. Besombes, J., C. Pronier, J. Bomo, P. Gripon, and V. Thibault. Journal of Hepatology, 2022. 77: S258-S258. ISI[000826275101267].
[WOS]. HBV_08_2022.

2. A Single Dose of anti-HBsAg Antibody-encoding mRNA-LNPs Suppressed HBsAg Expression: A Potential Cure of Chronic Hepatitis B Virus Infection. Chen, B., Y. Chen, J. Li, C. Wang, W. Song, Y. Wen, J. Lin, Y. Wu, and T. Ying. mBio, 2022. 13(4): e0161222. PMID[35862767]. PMCID[ PMC9426588].
[PubMed]. HBV_08_2022.

3. Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection. Chen, D., X. Tan, W. Chen, Y. Liu, C. Li, J. Wu, J. Zheng, H.C. Shen, M. Zhang, W. Wu, L. Wang, J. Xiong, J. Dai, K. Sun, J.D. Zhang, K. Xiang, B. Li, X. Ni, Q. Zhu, L. Gao, L. Wang, and S. Feng. Journal of Medicinal Chemistry, 2022. 65(16): p. 10938-10955. PMID[35973101].
[PubMed]. HBV_08_2022.

4. Identification of Estradiol Benzoate as an Inhibitor of HBx Using Inducible Stably Transfected HepG2 Cells Expressing HiBiT Tagged HBx. He, J., J. Wu, J. Chen, S. Zhang, Y. Guo, X. Zhang, J. Han, Y. Zhang, Y. Guo, Y. Lin, W. Yu, Y. Kong, Z. Shen, R. Mao, and J. Zhang. Molecules, 2022. 27(15): 5000. PMID[35956950]. PMCID[PMC9370419].
[PubMed]. HBV_08_2022.

5. HEC121120, a Novel Allosteric Modulator of HBV Core Protein Demonstrates Potent Antiviral Activities in Vitro and in Vivo. Lai, Q.Y., P. Wang, X.C. Liu, Q.Y. Ren, B.H. Gu, J. Li, and Y.F. Chen. Journal of Hepatology, 2022. 77: S854-S855. ISI[000826275104248].
[WOS]. HBV_08_2022.

6. VIR-2218 Plus VIR-3434 Combination Therapy Reduces Hepatitis B Virus Surface Antigen Levels in Vivo. Noack, J., J. Gall, H. Imam, Y. Anglero-Rodriguez, V. Jadhav, M.A. Schmid, A. Bakardjiev, L.A. Purcell, C. Hebner, and F. Lempp. Journal of Hepatology, 2022. 77: S871-S871. ISI[000826275104278].
[WOS]. HBV_08_2022.

7. Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model. Spunde, K., B. Vigante, U.N. Dubova, A. Sipola, I. Timofejeva, A. Zajakina, J. Jansons, A. Plotniece, K. Pajuste, A. Sobolev, R. Muhamadejev, K. Jaudzems, G. Duburs, and T. Kozlovska. Pharmaceuticals, 2022. 15(7): 773. PMID[35890072]. PMCID[PMC9317397].
[PubMed]. HBV_08_2022.

8. ABI-4334, a Novel Inhibitor of Hepatitis B Virus Core Protein, Promotes Formation of Empty Capsids and Prevents Covalently Closed Circular DNA Formation by Disruption of Incoming Capsids. Unchwaniwala, N., W. Delaney, and K.M. Kitrinos. Journal of Hepatology, 2022. 77: S844-S845. ISI[000826275104227].
[WOS]. HBV_08_2022.

9. HEC96719, a Novel FXR Agonist, Inhibits HBV Infection in Vitro and in Vivo. Wang, P., Q.Y. Lai, X.Y. Yang, J. Li, and Y.F. Chen. Journal of Hepatology, 2022. 77: S254-S254. ISI[000826275101259].
[WOS]. HBV_08_2022.

10. GST-HG141 Inhibits de Novo HBV cccDNA Formation in Cultured Primary Human Hepatocytes. Zhang, D., W.Q. Wu, S.K. Chen, Z. Yu, V. Bichko, J. Mao, Z.G. Jiang, H.Y. He, L. Jian, and S.H. Chen. Journal of Hepatology, 2022. 77: S832-S833. ISI[000826275104203].
[WOS]. HBV_08_2022.

11. Rapamycin Inhibits Hepatitis B Virus Covalently Closed Circular DNA Transcription by Enhancing the Ubiquitination of HBx. Zhang, Y., L. Li, S.T. Cheng, Y.P. Qin, X. He, F. Li, D.Q. Wu, F. Ren, H.B. Yu, J. Liu, J. Chen, J.H. Ren, and Z.Z. Zhang. Frontiers in Microbiology, 2022. 13: 850087. PMID[36033851]. PMCID[PMC9403416].
[PubMed]. HBV_08_2022.

Patent Citations

12. Benzothiazolyl Bicyclo[1.1.1]pentane Derivatives for the Treatment and Prophylaxis of Hepatitis B Virus Infection. Yun, H., B. Zhang, and X. Zheng. Patent. 2022. 2022-EP54316 2022180003: 123pp.
[Patent]. HBV_08_2022.